E. J. Louis, M. Resche-Rigon, D. Laharie, J. Satsangi, N. Ding, et al.. Withdrawal of infliximab or anti-metabolite therapy in Crohn's Disease patients in sustained remission on combination therapy: A randomized unblinded controlled trial (SPARE).
JOURNAL OF CROHNS & COLITIS, 2022, 16 (1), pp.I001.
⟨hal-03665872⟩